CSat Investment Advisory’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$2.29M Sell
5,462
-2,058
-27% -$822K 1.92% 13
2020
Q4
$3.08M Sell
7,520
-288
-4% -$120K 2.87% 6
2020
Q3
$3.23M Buy
7,808
+4,646
+147% +$1.87M 0.29% 31
2020
Q2
$1.23M Sell
3,162
-108
-3% -$40.4K 0.15% 67
2020
Q1
$1.03M Sell
3,270
-405
-11% -$137K 0.22% 63
2019
Q4
$1.35M Sell
3,675
-418
-10% -$133K 0.35% 54
2019
Q3
$1.05M Sell
4,093
-45
-1% -$12.6K 0.33% 60
2019
Q2
$1.1M Buy
4,138
+144
+4% +$36.5K 0.39% 54
2019
Q1
$1.06M Sell
3,994
-783
-16% -$226K 0.54% 46
2018
Q4
$1.37M Buy
4,777
+638
+15% +$202K 0.82% 28
2018
Q3
$1.4M Buy
4,139
+17
+0.4% +$5.52K 0.8% 32
2018
Q2
$1.23M Buy
+4,122
New +$1.21M 0.65% 37

Other funds holding HUM

CSat Investment Advisory's HUM Position: Q1 2021 in Review

CSat Investment Advisory reduced its Humana (HUM) stake by 27% in Q1 2021, selling an estimated $822K and leaving 5,462 shares worth $2.29M. The position accounts for 1.92% of the portfolio, ranked #13.

CSat Investment Advisory first reported a position in HUM in Q2 2018 and has held it in 12 quarters since. The position peaked at $3.23M in Q3 2020. 877 funds tracked by Wall St. Rank hold HUM as of Q1 2021.

  • CSat Investment Advisory held 5,462 shares of Humana worth $2.29M as of Q1 2021.
  • CSat Investment Advisory sold 2,058 Humana shares in Q1 2021, an estimated $822K.
  • Humana made up 1.92% of CSat Investment Advisory's portfolio in Q1 2021, its #13 holding.
  • CSat Investment Advisory first reported a position in Humana in Q2 2018 and has held it in 12 quarters since.
  • CSat Investment Advisory's Humana position peaked at $3.23M in Q3 2020.
  • 877 funds tracked by Wall St. Rank held Humana as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.